[1]许 磊,张拓伟,王新冰,等.二维斑点追踪成像技术评价益气活血化瘀方改善冠脉介入术后患者左心室功能的研究[J].陕西中医,2021,(9):1226-1228,1301.[doi:DOI:10.3969/j.issn.1000-7369.2020.09.019]
点击复制

二维斑点追踪成像技术评价益气活血化瘀方改善冠脉介入术后患者左心室功能的研究
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年9期
页码:
1226-1228,1301
栏目:
临床研究
出版日期:
2021-09-05

文章信息/Info

作者:
许 磊张拓伟王新冰屈文涛
(西安市中医医院,陕西 西安 710021)
关键词:
经皮冠状动脉介入术 益气活血化瘀方 二维斑点追踪成像 超声心动图 心肌应变 左心室功能
分类号:
R 541
DOI:
DOI:10.3969/j.issn.1000-7369.2020.09.019
文献标志码:
A
摘要:
目的:探讨二维斑点追踪成像技术(2D-STI)在评价益气活血化瘀方改善经皮冠状动脉介入术(PCI)术后患者左心室功能的价值。方法:以90例急性心肌梗死后行经皮冠脉介入术(PCI)患者为研究对象,分为对照组和治疗组。对照组术后采用常规西医治疗,治疗组在对照组基础上采用益气活血化瘀方。应用超声诊断仪评估患者术后10 d、术后30 d、术后60 d的左心室舒张末内径(LEVD)、左心房内径(LAD)、左心室射血分数(EF)。应用2D-STI检测患者术后10 d、术后30 d、术后60 d的左心室整体纵向应变(GLS)、圆周应变(GCS)、径向应变(GRS)。结果:两组PCI术后10 d、术后30 d、术后60 d,其EF值均逐渐增高。两组PCI术后60 d组间比较,治疗组GLS、GCS、GRS值大于对照组,差异有统计学意义(均P<0.05)。结论:通过2D-STI技术量化评价,提示益气活血化瘀方联合常规西医治疗可改善PCI术后患者左心室功能。

参考文献/References:

[1] Aradi D,Dezsi D,Veress G,et al.Prolonging ticagrelor beyond a year of acute coronary syndrome:Worth or harmful[J].Curr Vasc Pharmacol,2018,16(5):446-450.
[2] Hagemann RA,Hoffmann S,Brainin P,et al.Early diastolic strain rate by two-dimensional speckle tracking echocardiography is a predictor of coronary artery disease and cardiovascular events in stable angina pectoris[J].Int Journal Cardiovasc Imaging,2020,36(7):1249-1260.
[3] 陈武君,庄洪标,黄火剑,等.益气活血化瘀方联合西药对冠心病心衰介入术后左心室功能及生活质量影响的研究[J].陕西中医,2017,38(11):1517-1518.
[4] 蔡振东,胡 凯,刘宗军.冠心病患者药物支架内再狭窄的影响因素分析[J].实用医学杂志,2017,33(17):2904-2906.
[5] 黄正新,王召亿,李鑫辉.冠心病的中西医诊断思维差异认识的比较分析[J].陕西中医,2017,38(10):1374-1375.
[6] 文颖娟.基于国医大师雷忠义痰瘀互结理论的临床思维启示[J].陕西中医,2020,41(7):948-950,998.
[7] 吕永飞,陈爱莲.益心康泰胶囊治疗冠心病经皮冠状动脉介入术术后疗效及对患者血流变、血管内皮功能的影响[J].陕西中医,2019,40(6):714-717.
[8] 陈良娟,陈爱莲,周双红.芪参通瘀汤治疗急性冠脉综合征介入术后患者53例[J].中国中医药科技,2020,27(2):249-250.
[9] 朱德建,吕紫梦.冠心病的病因病机及辨证分型[J].中医药信息,2019,36(2):95-99.
[10] 胡国恒,朱荣华,肖 青,等.益气活血组方对大鼠缺血心肌血管新生作用及对血管内皮生长因子和碱性成纤维生长因子的影响[J].世界中医药,2017,12(10):2419-2422.
[11] 但国梅,韩晓霞,刘秀红.益气活血方配合西药治疗冠心病疗效及对血浆hs-CRP、NT-pro BNP水平影响[J].陕西中医,2017,38(8):1001-1002.
[12] 高学敏.养心理论与临床实践[M].青岛:青岛出版社,2017:195-196.
[13] 孟 媛,毛秉豫.益气活血法在冠心病治疗性血管新生中研究进展[J].辽宁中医药大学学报,2017,19(2):215-218.
[14] 黄 宇,王肖龙,赵汉君,等.益气活血化痰方对冠状动脉介入术后慢血流病人血管内皮功能和炎症反应的改善作用[J].中西医结合心脑血管病杂志,2020,18(5):708-711.
[15] 刘 红,张玲燕,杨 玲.血府逐瘀汤治疗冠心病介入术后心绞痛临床研究[J].陕西中医,2019,40(5):594-596.
[16] 王瑾茜,胡国恒,蔺晓源,等.益气活血方对气虚血瘀型冠心病模型大鼠的影响研究[J].湖南中医药大学学报,2020,40(5):529-534.
[17] Montalescot G,Sechtem U,Achenbach S,et al.2013 ESC guidelines on the management of stable coronary artery disease:The task force on the management of stable coronary artery disease of the European society of cardiology[J].Eur Heart Journal,2013,34(38):2949-3003.
[18] Hagemann CA,Hoffmann S,Hagemann RA,et al.Usefulness of layer-specific strain in diagnosis of coronary artery disease in patients with stable angina pectoris[J].Int Journal Cardiovasc Imaging,2019,35(11):1989-1999.
[19] Lustosa RP,Fortuni F,Vander BP,et al.Left ventricular myocardial work in the culprit vessel territory and impact on left ventricular remodelling in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention[J].Eur Heart Journal Cardiovasc Imaging,2021,22(3):339-347.
[20] Liu K,Wang Y,Hao Q,et al.Evaluation of myocardial viability in patients with acute myocardial infarction:Layer-specific analysis of 2-dimensional speckle tracking echocardiography[J].Medicine(Baltimore),2019,98(3):e139-e159.
[21] Zhong J,Liu P,Li S,et al.A comparison of three-dimensional speckle tracking echocardiography parameters in predicting left ventricular remodeling[J].Journal Healthc Eng,2020,20(2):884-887.
[22] Howard QK,Mccabe M,Cheng A,et al.Left ventricular endocardial and epicardial strain changes with apical myocardial ischemia in an open-chest porcine model[J].Physiol Rep,2016,4(24):e130-e142.

相似文献/References:

[1]范国萍,闫新慧.通络养心汤对急性心肌梗死经皮冠状动脉介入术后高缺血风险患者血小板抑制率及出血事件的影响*[J].陕西中医,2019,(8):1025.
 FAN Guoping,YAN Xinhui..Effect of Tongluo Yangxin decoction in treating acute myocardial infarction combined with high risk of ischemia and evaluate the platelet inhibition rate and hemorrhage events risk[J].,2019,(9):1025.

备注/Memo

备注/Memo:
基金项目:陕西省中医药管理局科研项目(LCPT057)
更新日期/Last Update: 2021-09-10